Background Integrase strand-transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is
recommended for human immunodeficiency virus (HIV) management. Although studies …

Background Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been
associated with excess weight gain. Whether similar gains are seen after switch to INSTIs …

Background: Integrase strand transfer inhibitors (INSTIs) have been associated with weight
gain among women living with HIV. We aimed to investigate the association between INSTIs …

Objective: Excessive weight gain has been reported with integrase strand transfer inhibitors
(INSTIs). We evaluated weight changes in virologically suppressed adults with HIV who …

Background Integrase strand transfer inhibitors (INSTIs) are associated with weight gain in
people with HIV (PWH). Less is known about the risk of other metabolic outcomes such as …

Background Global antiretroviral therapy has entered a new era. Integrase strand transfer
inhibitor (INSTI) has become the first choice in acquired immunodeficiency syndrome (AIDS) …

Objective: The primary objective was to explore weight and BMI changes in people with HIV
(PWH) undergoing integrase strand transfer inhibitors (INSTI)-based regimens (vs. non …

Introduction Weight gain following antiretroviral therapy (ART) initiation is common,
potentially predisposing some persons with HIV (PWH) to cardio‐metabolic disease. We …

Background Unwanted weight gain affects some people living with human
immunodeficiency virus (HIV) who are prescribed integrase strand transfer inhibitors …

Although INSTI-based regimens are highly efficacious for viral suppression, they appear to
cause more weight gain and treatment emergent obesity than non-INSTI-based regimens …